Clinical Trial Update: Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

Clinical trial update for Zithromax-SR 2g under a regulatory post-marketing commitment shows the study is completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• Zithromax-SR 2g (azithromycin)

Snippet

Sponsor: Pfizer | Conditions: Bacterial Infections | Status: COMPLETED | Results posted: 2012-05-01